Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 2
1999 2
2000 1
2001 3
2002 2
2003 4
2004 2
2005 3
2006 3
2007 4
2008 5
2009 3
2010 4
2011 3
2012 2
2013 3
2014 3
2020 1
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond.
Jennings SV, Finnerty CC, Hobart JS, Martín-Martínez M, Sinclair KA, Slee VM, Agopian J, Akin C, Álvarez-Twose I, Bonadonna P, Bowman AS, Brockow K, Bumbea H, de Haro C, Fok JS, Hartmann K, Hegmann N, Hermine O, Kalisiak M, Katelaris CH, Kurz J, Marcis P, Mayne D, Mendoza D, Moussy A, Mudretzkyj G, Vaia NN, Niedoszytko M, Elberink HO, Orfao A, Radia DH, Rosenmeier S, Ribada E, Schinhofen W, Schwaab J, Siebenhaar F, Triggiani M, Tripodo G, Velazquez R, Wielink Y, Wimazal F, Yigit T, Zubrinich C, Valent P. Jennings SV, et al. Among authors: wimazal f. J Allergy Clin Immunol Pract. 2022 Aug;10(8):2039-2051. doi: 10.1016/j.jaip.2022.06.018. Epub 2022 Jun 28. J Allergy Clin Immunol Pract. 2022. PMID: 35777651 Free article.
Standards and impact of hematopathology in myelodysplastic syndromes (MDS).
Valent P, Orazi A, Büsche G, Schmitt-Gräff A, George TI, Sotlar K, Streubel B, Beham-Schmid C, Cerny-Reiterer S, Krieger O, van de Loosdrecht A, Kern W, Ogata K, Wimazal F, Várkonyi J, Sperr WR, Werner M, Kreipe H, Horny HP. Valent P, et al. Among authors: wimazal f. Oncotarget. 2010 Nov;1(7):483-96. doi: 10.18632/oncotarget.101104. Oncotarget. 2010. PMID: 21317447 Free PMC article. Review.
Impact of age and comorbidity in myelodysplastic syndromes.
Stauder R, Nösslinger T, Pfeilstöcker M, Sperr WR, Wimazal F, Krieger O, Valent P. Stauder R, et al. Among authors: wimazal f. J Natl Compr Canc Netw. 2008 Oct;6(9):927-34. doi: 10.6004/jnccn.2008.0070. J Natl Compr Canc Netw. 2008. PMID: 18926101 Review.
[Individualized management and therapy of myelodysplastic syndromes].
Stauder R, Wimazal F, Nösslinger T, Krieger O, Sperr WR, Sill H, Pfeilstöcker M, Valent P. Stauder R, et al. Among authors: wimazal f. Wien Klin Wochenschr. 2008;120(17-18):523-37. doi: 10.1007/s00508-008-1058-6. Wien Klin Wochenschr. 2008. PMID: 18988005 Review. German.
Treatment concepts for elderly patients with acute myeloid leukemia.
Sperr WR, Hauswirth AW, Wimazal F, Knöbl P, Geissler K, Valent P. Sperr WR, et al. Among authors: wimazal f. Wien Klin Wochenschr. 2003 Aug 14;115(13-14):505-14. doi: 10.1007/BF03041034. Wien Klin Wochenschr. 2003. PMID: 13677269 Review.
Impact of HFE gene variants on iron overload, overall survival and leukemia-free survival in myelodysplastic syndromes.
Schneeweiss-Gleixner M, Greiner G, Herndlhofer S, Schellnegger J, Krauth MT, Gleixner KV, Wimazal F, Steinhauser C, Kundi M, Thalhammer R, Schwarzinger I, Hoermann G, Esterbauer H, Födinger M, Valent P, Sperr WR. Schneeweiss-Gleixner M, et al. Among authors: wimazal f. Am J Cancer Res. 2021 Mar 1;11(3):955-967. eCollection 2021. Am J Cancer Res. 2021. PMID: 33791166 Free PMC article.
48 results